Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.

Vanderbilt investigators have developed a way to detect malaria that is faster and more sensitive than current clinical methods — a development that has the potential to make malaria detection significantly less expensive and more stable.

Researchers at Vanderbilt University Medical Center have received more than $11 million in new grant support aimed at slowing the growing burden of diabetes.

Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).

A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.

Researchers at Vanderbilt University Medical Center have obtained the crystal structure of a toxin from the bacterium Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

Vanderbilt investigators have identified a new biomarker to assess platelet function.